XG 102

XG-102, a TAT-coupled dextrogyre peptide inhibiting the c-Jun N-terminal kinase, was shown efficient in the treatment of experimental uveitis. Research show that XG-102 peptide has potential for treating intraocular inflammation.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-141
CAS	1198367-70-2
Synonyms/Alias	AM 111;XG 102 peptide;D-JNKI-1
M.F/Formula	C164H285N65O41
M.W/Mr.	3823.49
Sequence	H-D-Asp-D-Gln-D-Ser-D-Arg-D-Pro-D-Val-D-Gln-D-Pro-D-Phe-D-Leu-D-Asn-D-Leu-D-Thr-D-Thr-D-Pro-D-Arg-D-Lys-D-Pro-D-Arg-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-Gly-OH
Labeling Target	c-Jun N-terminal kinase (JNK)
Activity	Inhibitor
Biological Activity	XG-102, a TAT-coupled dextrogyre peptide inhibiting the c-Jun N-terminal kinase, was shown efficient in the treatment of experimental uveitis.
Areas of Interest	Inflammation
Disease	Intraocular inflammation
Target	JNK

CAT#	Product Name	Inquiry
10-101-284	[Ala1,3,11,15]-Endothelin 1	Inquiry
10-101-336	Indium In-111 pentetreotide	Inquiry
10-101-215	Oxytocin Acetate	Inquiry
10-101-97	Peptide YY (human) Acetate	Inquiry
10-101-12	Dynorphin A(1-13)	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.